These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 18298929)
21. [Voriconazole safety: short review of clinical data]. Veselov AV; Belousov DIu Antibiot Khimioter; 2006; 51(3-4):19-25. PubMed ID: 17165257 [No Abstract] [Full Text] [Related]
22. [Careful: skins cancers and voriconazole]. Schmutz JL; Trechot P Ann Dermatol Venereol; 2011 Nov; 138(11):805-6. PubMed ID: 22078051 [No Abstract] [Full Text] [Related]
23. Voriconazole in the treatment of fungal eye infections: a review of current literature. Hariprasad SM; Mieler WF; Lin TK; Sponsel WE; Graybill JR Br J Ophthalmol; 2008 Jul; 92(7):871-8. PubMed ID: 18577634 [TBL] [Abstract][Full Text] [Related]
24. The role of voriconazole in the treatment of central nervous system blastomycosis. Ta M; Flowers SA; Rogers PD Ann Pharmacother; 2009 Oct; 43(10):1696-700. PubMed ID: 19724015 [TBL] [Abstract][Full Text] [Related]
25. Voriconazole-a new therapeutic agent with an extended spectrum of antifungal activity. Donnelly JP; De Pauw BE Clin Microbiol Infect; 2004 Mar; 10 Suppl 1():107-17. PubMed ID: 14748807 [TBL] [Abstract][Full Text] [Related]
27. Treatment of protothecosis with voriconazole. Dalmau J; Pimentel CL; Alegre M; Sanchez F; Gurgui M; Roé E; Alomar A J Am Acad Dermatol; 2006 Nov; 55(5 Suppl):S122-3. PubMed ID: 17052532 [No Abstract] [Full Text] [Related]
28. Efficacy of voriconazole in a murine model of cryptococcal central nervous system infection. Serena C; Pastor FJ; Mariné M; Rodríguez MM; Guarro J J Antimicrob Chemother; 2007 Jul; 60(1):162-5. PubMed ID: 17483143 [TBL] [Abstract][Full Text] [Related]
29. Use of voriconazole in the treatment of fungal keratitis. Jurkunas UV; Langston DP; Colby K Int Ophthalmol Clin; 2007; 47(2):47-59. PubMed ID: 17450006 [No Abstract] [Full Text] [Related]
30. Breakthrough zygomycosis during empirical voriconazole therapy in febrile patients with neutropenia. Oren I Clin Infect Dis; 2005 Mar; 40(5):770-1. PubMed ID: 15714432 [No Abstract] [Full Text] [Related]
31. Madurella mycetomatis mycetoma treated successfully with oral voriconazole. Lacroix C; de Kerviler E; Morel P; Derouin F; Feuilhade de Chavin M Br J Dermatol; 2005 May; 152(5):1067-8. PubMed ID: 15888176 [No Abstract] [Full Text] [Related]
32. Secondary prophylaxis with voriconazole in a leukemic patient with pulmonary aspergillosis. Uriz J; de Andoin NG; Calvo C; Landa J; Onate E; Nogues A; Guerrero R Pediatr Infect Dis J; 2007 Oct; 26(10):971-2. PubMed ID: 17901816 [No Abstract] [Full Text] [Related]
33. Drug interaction between voriconazole and calcineurin inhibitors in allogeneic hematopoietic stem cell transplant recipients. Mori T; Aisa Y; Kato J; Nakamura Y; Ikeda Y; Okamoto S Bone Marrow Transplant; 2009 Sep; 44(6):371-4. PubMed ID: 19270729 [TBL] [Abstract][Full Text] [Related]
34. [Treatment of ABPA: a place for voriconazole and omalizumab?]. Mulliez P Rev Mal Respir; 2010 Sep; 27(7):670-2. PubMed ID: 20863965 [No Abstract] [Full Text] [Related]
35. Efficacy of voriconazole for Scedosporium apiospermum skull base osteomyelitis: case report and literature review. Vasoo S; Yeo SB; Lim PL; Ang BS; Lye DC Int J Antimicrob Agents; 2008 Feb; 31(2):184-5. PubMed ID: 18083011 [No Abstract] [Full Text] [Related]
36. Voriconazole-induced blistering in the setting of graft versus host disease: A report of 2 patients. Conlon JD; Dauenhauer M; Tonkovic-Capin V; Talano J; Margolis D; Drolet BA; Fairley JA J Am Acad Dermatol; 2008 Mar; 58(3):484-7. PubMed ID: 18280346 [TBL] [Abstract][Full Text] [Related]